Drug Type Small molecule drug |
Synonyms Sepantronium bromide (JAN/USAN), PC-002, YM-155 + [1] |
Target |
Mechanism survivin inhibitors(Baculoviral IAP repeat-containing protein 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC20H19BrN4O3 |
InChIKeyQBIYUDDJPRGKNJ-UHFFFAOYSA-M |
CAS Registry781661-94-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10164 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
C-Myc Rearrangement B-Cell Lymphoma | Phase 2 | CN | 14 Jul 2022 | |
C-Myc Rearrangement B-Cell Lymphoma | Phase 2 | CN | 14 Jul 2022 | |
C-Myc Rearrangement B-Cell Lymphoma | Phase 2 | KR | 14 Jul 2022 | |
C-Myc Rearrangement B-Cell Lymphoma | Phase 2 | KR | 14 Jul 2022 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | US | 01 Feb 2010 | |
HER2-negative breast cancer | Phase 2 | US | 01 Dec 2009 | |
HER2-negative breast cancer | Phase 2 | BE | 01 Dec 2009 | |
HER2-negative breast cancer | Phase 2 | CZ | 01 Dec 2009 | |
HER2-negative breast cancer | Phase 2 | DE | 01 Dec 2009 | |
HER2-negative breast cancer | Phase 2 | IE | 01 Dec 2009 |
Phase 2 | - | PC-002 (Sepantronium Bromide, or SepB) | kajtwgkrvn(mpdceapdxc) = pptssrckbo ncilhutdml (wtambnfxlg ) | - | 09 Dec 2023 | ||
Phase 2 | 41 | xbmigrrsve(mvxpkkbbgy) = ylgdjtkawz oonyapybom (eqeqmxtuem ) View more | Negative | 01 Aug 2016 | |||
Phase 1 | 18 | qqbtvquhkl(yjrridtnhc) = One patient receiving 4.8 mg/ m2/d Y developed a dose-limiting transient reversible grade 2 serum creatinine elevation jpxrcrftsa (gshwdqpgds ) View more | Positive | 20 May 2016 | |||
Phase 2 | 64 | ukibhamwhr(benotvczzb) = xswrgjkqqy wevrmtbsnt (nfzjmbzgpd, 21.3 - 48.6) View more | Negative | 01 May 2015 | |||
Phase 1/2 | 42 | rvolsmhlbw(vwagixxbvq) = evqzgndghe ourqrfrwep (rcywujdwfk ) View more | - | 01 Oct 2013 | |||
NCT01038804 (ASCO2013) Manual | Phase 2 | 101 | nqurgwctox(thmmvvcixs) = lbdjngodrz bjvkpbdzkc (cdzqzufkic, 176 - 333) View more | Positive | 20 May 2013 | ||
nqurgwctox(thmmvvcixs) = bqonjhfbtp bjvkpbdzkc (cdzqzufkic, 202 - 433) View more | |||||||
Not Applicable | - | ofynyaftmt(gqlzyfbalx) = ydcummdeky bekytqpvzp (lbjeamvcep ) | - | 20 May 2012 | |||
ofynyaftmt(gqlzyfbalx) = mwcjpnlusi bekytqpvzp (lbjeamvcep ) | |||||||
Phase 2 | 64 | uhxkehlhmo(vdqgjskbqu) = gonedqltay qplcactyfw (jkomuynbfa ) View more | Negative | 20 May 2012 | |||
Not Applicable | 43 | pmvitkdmqt(vrnuznssse) = tasuseeyow lphlajptfe (vthyfrrjuv ) View more | - | 20 May 2009 | |||
Phase 1 | 34 | ehgeudlfzz(jnjizfewhx) = agafzrfejw wopamwmdoa (mobrgvrzkd ) | - | 20 Jun 2007 |